Comments on: Same old duet: drug companies and psychiatry

By: Anon in FLA

Anon in FLA — Thu, 26 May 2011 12:59:54 +0000

I’ve suffered with anxiety attacks for many years.It’s distressing to read things like this because it paints all psychiatrists and anti-anxiety meds as some kind of evil instead of the lifesavers they can actually be for many of us. This is an unfair generalization about a helpful profession and medicines that really make a difference between living and dying.

LikeLike

By: Dr. Bob

Dr. Bob — Tue, 10 May 2011 22:35:33 +0000

Carolyn, you wrote this previously in another post that I just looked up:

“Biederman is, according to the New York Times, the world’s most prominent advocate of diagnosing bipolar disorder in even the tiniest children, and of using anti-psychotic medicines to treat the disease, even though much of his work has been underwritten by drug makers for whom he privately consults. His work personally helped to fuel a controversial 40-fold increase from 1994 to 2003 in the diagnosis of pediatric bipolar disorder. Two of his most recent controversies: the use of anti-psychotic drugs in small children, and conflicts of interest in medicine. In fact, an inquiry by Iowa Senator Charles E. Grassley revealed last year that Biederman earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 – but failed to report all but about $200,000 of this income to university officials, according to information given Congressional investigators.”

Why is this guy still on Harvard’s payroll?

LikeLike

By: Eddie

Eddie — Wed, 06 Apr 2011 23:03:01 +0000

Thanks for sharing Alison’s work with us here. It’s quite unbelievable how the drug companies have shrinks on their payroll and nobody seems to mind?!?! And Harvard taking TWO YEARS to investigate Biederman? There’s somebody on the take on THAT investigative team.

LikeLike